By “Early treatment may help people avoid disease progression and avoid hospitalization,” Janet Woodcock, director of the Food and Drug Administration’s Center for Drug Evaluation and Research, said on a conference call along with Azar.The FDA on Monday gave emergency use authorization to Lilly’s antibody for anyone over age 65 who is recently diagnosed with mild-to-moderate COVID-19, and for patients age 12 and older who have an underlying health condition putting them at risk for serious illness. The agency said the treatment should not be used in patients already hospitalized with...…By “Early treatment may help people avoid disease progression and avoid hospitalization,” Janet Woodcock, director of the Food and Drug Administration’s Center for Drug Evaluation and Research, said on a conference call along with Azar.The FDA on Monday gave emergency use authorization to Lilly’s antibody for anyone over age 65 who is recently diagnosed with mild-to-moderate COVID-19, and for patients age 12 and older who have an underlying health condition putting them at risk for serious illness. The agency said the treatment should not be used in patients already hospitalized with...WW…

By (Reuters) - Drugmakers Amgen Inc and AstraZeneca Plc said on Tuesday a pivotal trial found that their experimental medication tezepelumab significantly reduced asthma attacks for people with severe forms of the respiratory condition compared to a placebo.The partners said that the year-long trial met its primary goal in patients with severe asthma who were also receiving standard care, including medium- or high-dose inhaled corticosteroids plus at least one other controller medication.The drug was also shown to work in a subgroup of patients with low levels of a type of white blood cell,...…By (Reuters) - Drugmakers Amgen Inc and AstraZeneca Plc said on Tuesday a pivotal trial found that their experimental medication tezepelumab significantly reduced asthma attacks for people with severe forms of the respiratory condition compared to a placebo.The partners said that the year-long trial met its primary goal in patients with severe asthma who were also receiving standard care, including medium- or high-dose inhaled corticosteroids plus at least one other controller medication.The drug was also shown to work in a subgroup of patients with low levels of a type of white blood cell,...WW…

By (Reuters) - U.S. regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co’s bamlanivimab based on trial data showing that a one-time infusion of the treatment reduced the need for hospitalization or emergency room visits in high-risk COVID-19 patients.The drug is a monoclonal antibody – a widely used class of biotech drugs which in this...…By (Reuters) - U.S. regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co’s bamlanivimab based on trial data showing that a one-time infusion of the treatment reduced the need for hospitalization or emergency room visits in high-risk COVID-19 patients.The drug is a monoclonal antibody – a widely used class of biotech drugs which in this...WW…

Feb 28 (Reuters) - As a new coronavirus spreads quickly around the world, U.S. health officials say they are "aggressively" assessing how long it can survive on surfaces to better understand the risk of transmission. Cleaning lady with a bucket and cleaning products on blurred background .© Getty Cleaning lady with a bucket and cleaning products on blurred background . Based on what is known about similar coronaviruses, disease experts say the new outbreak of the virus, named COVID-19, is mainly spread from person to person through coughing or sneezing. Contact with fecal matter from an...…Feb 28 (Reuters) - As a new coronavirus spreads quickly around the world, U.S. health officials say they are "aggressively" assessing how long it can survive on surfaces to better understand the risk of transmission. Cleaning lady with a bucket and cleaning products on blurred background .© Getty Cleaning lady with a bucket and cleaning products on blurred background . Based on what is known about similar coronaviruses, disease experts say the new outbreak of the virus, named COVID-19, is mainly spread from person to person through coughing or sneezing. Contact with fecal matter from an...WW…